EnginZyme

EnginZyme, based in Stockholm, offers an appealing bio alternative to traditional fossil-based chemical production. By providing sustainable biochemical solutions with lower environmental impact and energy consumption, EnginZyme addresses key concerns in traditional chemical processes, such as environmental harm and high energy use. Their B2B model appeals to industries seeking greener production methods. Supported by investors like Sofinnova Partners, SEB Venture Capital, and Industrifonden, the company is well-positioned for growth in sustainability-focused biotech and health tech sectors. EnginZyme's innovative approach may give it a competitive edge as businesses increasingly prioritize eco-friendly practices.